Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0001144204-13-001056

CEO and President bought 2,900 shares at an average $0.17 ($506)

From the SEC's structured data for this filing

Trades in this filing

Riley Jeffrey Scott · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-01-07 Purchase : show line 1 in the form +5 $1.71 $9 7,505 D
2013-01-07 Purchase : show line 2 in the form +2,895 $0.17 $498 10,400 D
Open-market purchases · 2,900 sh · avg $0.17 · $506
Loading xslF345X03/v331583_4.xml…